SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of GeoMx® DSP ...
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a peer-reviewed publication ...
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced the ...
NanoString’s GeoMX Digital Spatial Profiler was at the heart of a patent lawsuit filed by 10x Genomics. (NanoString Image) NanoString announced Wednesday that it will be acquired by Bruker, ending the ...
Massachusetts General Hospital-led study uncovers that patient immune cell abundance and response are directly related to SARS-CoV-2 virus location Figure A: SARS Co-V2 is visualized in infected lung ...
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a peer-reviewed paper published in Nature Genetics ...
Bruker Corp. (NASDAQ:BRKR) said it plans to ask for a stay and appeal a ruling on an injunction that will block the sale of NanoString's GeoMX products in the U.S. “We respectfully disagree with the ...
Cancer Transcriptome Atlas is the First in a Portfolio of GeoMx Products That Enable Spatial Genomics Using the Installed Base of Nearly 20,000 Next Gen Sequencers NanoString Technologies, Inc.
NanoString’s GeoMX Digital Spatial Profiler was at the heart of a patent lawsuit filed by 10x Genomics. (NanoString Image) Seattle-based publicly traded biotech company NanoString Technologies said in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results